SMC | NICE | |||||||||||
Year | Number | Median (months) | Range (months) | Total | Median (months) | Range (months) | MTAs | Median (months) | Range (months) | STAs | Median (months) | Range (months) |
2000 | NA | 4 | 14 | 4–19 | 4 | 14 | 4–19 | NA | NA | NA | ||
2001 | NA | 4 | 13 | 3–17 | 4 | 13 | 3–17 | NA | NA | NA | ||
2002 | 23 | 5 | 1–23 | 11 | 18 | 9–29 | 11 | 18 | 9–29 | NA | NA | NA |
2003 | 57 | 7 | 1–30 | 10 | 34 | 7–46 | 10 | 34 | 7–46 | NA | NA | NA |
2004 | 59 | 8 | 1–32 | 13 | 22 | 2–35 | 13 | 22 | 2–35 | NA | NA | NA |
2005 | 71 | 8 | 1–29 | 2 | 11 | 3–19 | 2 | 11 | 3–19 | NA | NA | NA |
2006 | 94 | 6 | 1–44 | 21 | 21 | 6–77 | 19 | 21 | 6–77 | 2 | 19 | 17–20 |
2007 | 84 | 7 | 1–24 | 19 | 26 | 9–58 | 9 | 35 | 24–58 | 10 | 24.5 | 9–41 |
2008 | 72 | 7 | 1–30 | 21 | 26 | 2–60 | 11 | 36 | 2–60 | 10 | 12.5 | 5–37 |
2009 | 66 | 7 | 1–24 | 21 | 20 | 4–46 | 8 | 28.5 | 20–46 | 13 | 8 | 4–38 |
2010 | 30 | 10 | 1–30 | 4 | 29.5 | 4–35 | 1 | 35 | NA | 3 | 29 | 4–30 |
MTA, multiple technology assessments; NA, not applicable; NICE, National Institute of Health and Clinical Excellence; SMC, Scottish Medicines Consortium; STA, single technology assessment.